 Anti-HIV Agents
"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.
| Descriptor ID |
D019380
|
| MeSH Number(s) |
D27.505.954.122.388.077.088
|
| Concept/Terms |
Anti-HIV Agents- Anti-HIV Agents
- Agents, Anti-HIV
- Anti HIV Agents
- Anti-HIV Drugs
- Anti HIV Drugs
- Drugs, Anti-HIV
- AIDS Drugs
- Drugs, AIDS
- Anti-AIDS Agents
- Agents, Anti-AIDS
- Anti AIDS Agents
- Anti-AIDS Drugs
- Anti AIDS Drugs
- Drugs, Anti-AIDS
|
Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".
This graph shows the total number of publications written about "Anti-HIV Agents" by people in this website by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1998 | 3 | 2 | 5 | | 1999 | 3 | 4 | 7 | | 2000 | 2 | 0 | 2 | | 2001 | 2 | 0 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 0 | 2 | | 2007 | 1 | 0 | 1 | | 2009 | 2 | 1 | 3 | | 2011 | 3 | 1 | 4 | | 2012 | 1 | 1 | 2 | | 2013 | 4 | 0 | 4 | | 2015 | 1 | 1 | 2 | | 2016 | 6 | 0 | 6 | | 2017 | 4 | 2 | 6 | | 2018 | 6 | 1 | 7 | | 2019 | 6 | 3 | 9 | | 2020 | 11 | 5 | 16 | | 2021 | 9 | 6 | 15 | | 2022 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles.
-
Musinguzi N, Pyra M, Bukusi EA, Mugo NR, Baeten JM, Haberer JE. Trajectories of Oral PrEP Adherence Among Young Kenyan Women: Implications for Promoting Effective PrEP Use. AIDS Behav. 2023 Jan; 27(1):171-181.
-
Johnson AK, Pyra M, Devlin S, Uvin AZ, Irby S, Blum C, Stewart E, Masinter L, Haider S, Hirschhorn LR, Ridgway JP. Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research. J Acquir Immune Defic Syndr. 2022 07 01; 90(S1):S141-S148.
-
Pagkas-Bather J, Duncan DT, Chen YT, Cursio J, Del Vecchio N, Mayer KH, Knox J, Hanson H, Eavou R, Schneider JA. Sleep Disturbance is Associated with Missing PrEP Doses Among Young Black Sexual Minority Men in The N2 study. AIDS Behav. 2022 Dec; 26(12):3827-3833.
-
Haberer JE, Mugo N, Bukusi EA, Ngure K, Kiptinness C, Oware K, Garrison LE, Musinguzi N, Pyra M, Valenzuela S, Thomas KK, Anderson PL, Thirumurthy H, Baeten JM. Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):251-260.
-
Fouché T, Del Vecchio N, Papadopoulou M, Sypsa V, Roussos S, Paraskevis D, Chanos S, Dedes N, Khanna A, Hotton A, Hatzakis A, Psichogiou M, Schneider JA. A Network Approach to Determine Optimization of PrEP Uptake in Athens, Greece. AIDS Behav. 2022 Aug; 26(8):2703-2712.
-
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C. A highly virulent variant of HIV-1 circulating in the Netherlands. Science. 2022 02 04; 375(6580):540-545.
-
Pyra M, Brewer R, Rusie L, Kline J, Willis I, Schneider J. Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence. J Acquir Immune Defic Syndr. 2022 02 01; 89(2):166-171.
-
Mulenga H, Musvosvi M, Mendelsohn SC, Penn-Nicholson A, Kimbung Mbandi S, Fiore-Gartland A, Tameris M, Mabwe S, Africa H, Bilek N, Kafaar F, Khader SA, Carstens B, Hadley K, Hikuam C, Erasmus M, Jaxa L, Raphela R, Nombida O, Kaskar M, Nicol MP, Mbhele S, Van Heerden J, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Walzl G, Naidoo K, Churchyard G, Hatherill M, Scriba TJ. Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis. Am J Respir Crit Care Med. 2021 12 15; 204(12):1463-1472.
-
Bunting SR, Feinstein BA, Hazra A, Garber SS. Effects of Patient Sexual Orientation and Gender Identity on Medical Students' Decision Making Regarding Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention: A Vignette-Based Study. Sex Transm Dis. 2021 12 01; 48(12):959-966.
-
Ngure K, Mugo NR, Bukusi EA, Kiptinness C, Oware K, Gakuo S, Musinguzi N, Pyra M, Garrison L, Baeten JM, Haberer JE. Pills, Injections, Rings, or Implants? PrEP Formulation Preferences of PrEP-Experienced African Women for HIV Prevention. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):e30-e32.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|